(WRBY) Warby Parker - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US93403J1060
WRBY: Eyeglasses, Sunglasses, Lenses, Accessories, Eye Exams
Warby Parker Inc. (NYSE:WRBY) operates as a direct-to-consumer eyewear brand, offering a wide range of eyewear products and services in the United States and Canada. The company provides prescription eyeglasses, sunglasses, single-vision lenses, progressive lenses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also sells accessories such as cases, lens kits with anti-fog spray, pouches, travel cases, lens cloths, anti-fog lens sprays, and sun clip-ons. These products are available through retail stores, the company’s website, and mobile apps. Additionally, Warby Parker offers eye exams and vision tests, enhancing its customer experience. The company, incorporated in 2009 and headquartered in New York, New York, has gained recognition for its affordable pricing, innovative try-on features, and socially conscious initiatives, including its Buy One, Give One program. Web URL: https://www.warbyparker.com.
Over the next three months, Warby Parker Inc. (NYSE:WRBY) is expected to experience moderate trading activity, with an average daily volume of 2.5 million shares. Based on the technical data, the stock is currently trading at $16.51, below its 50-day SMA of $18.92 and 200-day SMA of $19.43, indicating potential bearish momentum. The 20-day SMA of $15.36 suggests near-term support. The ATR of $1.20 signals moderate volatility. On the fundamental side, the company’s forward P/E of 40.65 reflects high valuation expectations, while the P/S ratio of 2.23 indicates strong revenue multiples. However, the negative RoE of -6.00% highlights profitability challenges. Overall, the stock is likely to remain range-bound, with potential downside risks tied to profitability concerns and macroeconomic conditions.
Additional Sources for WRBY Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
WRBY Stock Overview
Market Cap in USD | 2,053m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC Sub-Industry | Other Specialty Retail |
IPO / Inception | 2021-09-29 |
WRBY Stock Ratings
Growth Rating | -31.4 |
Fundamental | 6.01 |
Dividend Rating | 0.0 |
Rel. Strength | 39.3 |
Analysts | 4/5 |
Fair Price Momentum | 14.30 USD |
Fair Price DCF | 3.30 USD |
WRBY Dividends
No Dividends PaidWRBY Growth Ratios
Growth Correlation 3m | -89.6% |
Growth Correlation 12m | 43.6% |
Growth Correlation 5y | -16.7% |
CAGR 5y | -28.03% |
CAGR/Max DD 5y | -0.33 |
Sharpe Ratio 12m | -0.79 |
Alpha | 20.03 |
Beta | 1.453 |
Volatility | 69.55% |
Current Volume | 3688k |
Average Volume 20d | 2352.4k |
As of May 10, 2025, the stock is trading at USD 16.62 with a total of 3,688,012 shares traded.
Over the past week, the price has changed by +0.85%, over one month by +16.47%, over three months by -37.59% and over the past year by +33.60%.
Neither. Based on ValueRay Fundamental Analyses, Warby Parker is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 6.01 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of WRBY as of May 2025 is 14.30. This means that WRBY is currently overvalued and has a potential downside of -13.96%.
Warby Parker has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy WRBY.
- Strong Buy: 6
- Buy: 3
- Hold: 6
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, WRBY Warby Parker will be worth about 16.7 in May 2026. The stock is currently trading at 16.62. This means that the stock has a potential upside of +0.24%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 22.6 | 36.2% |
Analysts Target Price | 22.6 | 36.2% |
ValueRay Target Price | 16.7 | 0.2% |